S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Laser breakthrough could send stock soaring 2,467% (Ad)
Turkey’s central bank hikes interest rates again in further shift in economic policies
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Laser breakthrough could send stock soaring 2,467% (Ad)
Turkey’s central bank hikes interest rates again in further shift in economic policies
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Laser breakthrough could send stock soaring 2,467% (Ad)
Turkey’s central bank hikes interest rates again in further shift in economic policies
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
5 Sizzling Tech Companies on the Brink of Bullish Reversals
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Laser breakthrough could send stock soaring 2,467% (Ad)
Turkey’s central bank hikes interest rates again in further shift in economic policies
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
NASDAQ:ZYXI

Zynex (ZYXI) Stock Forecast, Price & News

$8.37
+0.34 (+4.23%)
(As of 09/21/2023 ET)
Compare
Today's Range
$7.98
$8.52
50-Day Range
$6.95
$9.89
52-Week Range
$6.88
$17.25
Volume
461,396 shs
Average Volume
672,015 shs
Market Capitalization
$300.73 million
P/E Ratio
18.20
Dividend Yield
N/A
Price Target
$19.63

Zynex MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
134.5% Upside
$19.63 Price Target
Short Interest
Bearish
27.60% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.75mentions of Zynex in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$270,720 Sold Last Quarter
Proj. Earnings Growth
36.59%
From $0.41 to $0.56 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.43 out of 5 stars

Medical Sector

210th out of 965 stocks

Electromedical Equipment Industry

6th out of 22 stocks


ZYXI stock logo

About Zynex (NASDAQ:ZYXI) Stock

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

ZYXI Price History

ZYXI Stock News Headlines

A Look At The Fair Value Of Zynex, Inc. (NASDAQ:ZYXI)
Zynex to Present at the Cantor Global Healthcare Conference
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Zynex Shares Rise 10% on Stock-Buyback Plan
Zynex Announces Share Repurchase Program
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Zynex Announces 1 Millionth Patient Milestone
Zynex Gains on New Therapy Products
Zynex, Inc Announces New Therapy Products
Zynex Reports Second Quarter 2023 Financial Results
Zynex earnings: here's what Wall Street expects
Earnings Preview For Zynex
Zynex, Inc. Sets Second Quarter 2023 Earnings Call
Zynex President Trades Company's Stock
Zynex Plans New $10M Stock Buyback Program
Why Shares of Zynex Are Up Wednesday
See More Headlines
Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

ZYXI Company Calendar

Last Earnings
7/27/2023
Today
9/22/2023
Next Earnings (Estimated)
10/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZYXI
Fax
N/A
Employees
900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.63
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$12.50
Forecasted Upside/Downside
+134.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$17.05 million
Pretax Margin
12.27%

Debt

Sales & Book Value

Annual Sales
$158.17 million
Cash Flow
$0.55 per share
Book Value
$1.77 per share

Miscellaneous

Free Float
19,199,000
Market Cap
$300.73 million
Optionable
Optionable
Beta
0.62
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Thomas SandgaardMr. Thomas Sandgaard (Age 64)
    Founder, Pres, CEO & Chairman
    Comp: $1.14M
  • Mr. Daniel J. MoorheadMr. Daniel J. Moorhead (Age 51)
    Chief Financial Officer
    Comp: $423.77k
  • Ms. Anna Lucsok (Age 36)
    Chief Operating Officer
    Comp: $356.25k
  • Mr. Steve Fox
    VP Of Sales
  • Mr. Donald Gregg
    Pres of Zynex Monitoring Solutions
  • Mr. Neil Friery
    Pres & COO of Zynex Monitoring Solutions, Inc.













ZYXI Stock - Frequently Asked Questions

Should I buy or sell Zynex stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZYXI shares.
View ZYXI analyst ratings
or view top-rated stocks.

What is Zynex's stock price forecast for 2023?

3 analysts have issued 12-month price objectives for Zynex's stock. Their ZYXI share price forecasts range from $12.50 to $28.00. On average, they expect the company's stock price to reach $19.63 in the next year. This suggests a possible upside of 134.5% from the stock's current price.
View analysts price targets for ZYXI
or view top-rated stocks among Wall Street analysts.

How have ZYXI shares performed in 2023?

Zynex's stock was trading at $13.91 at the beginning of the year. Since then, ZYXI stock has decreased by 39.8% and is now trading at $8.37.
View the best growth stocks for 2023 here
.

When is Zynex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our ZYXI earnings forecast
.

How were Zynex's earnings last quarter?

Zynex, Inc. (NASDAQ:ZYXI) released its earnings results on Thursday, July, 27th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.04 by $0.05. The firm had revenue of $44.95 million for the quarter, compared to analyst estimates of $44.50 million. Zynex had a trailing twelve-month return on equity of 26.71% and a net margin of 9.72%.

What ETF holds Zynex's stock ?

Syntax Stratified SmallCap ETF holds 8,191 shares of ZYXI stock, representing 0.42% of its portfolio.

What guidance has Zynex issued on next quarter's earnings?

Zynex issued an update on its third quarter 2023 earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $0.08-$0.10 for the period, compared to the consensus EPS estimate of $0.12. The company issued revenue guidance of $49.00 million-$51.00 million, compared to the consensus revenue estimate of $49.84 million.

What is Thomas Sandgaard's approval rating as Zynex's CEO?

81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees.

What is Zynex's stock symbol?

Zynex trades on the NASDAQ under the ticker symbol "ZYXI."

Who are Zynex's major shareholders?

Zynex's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.03%), State Street Corp (1.98%), Geode Capital Management LLC (1.21%), Point72 Asset Management L.P. (0.87%), Bank of New York Mellon Corp (0.83%) and Cambridge Investment Research Advisors Inc. (0.77%). Insiders that own company stock include Anna Lucsok, Daniel J Moorhead and Thomas Sandgaard.
View institutional ownership trends
.

How do I buy shares of Zynex?

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zynex's stock price today?

One share of ZYXI stock can currently be purchased for approximately $8.37.

How much money does Zynex make?

Zynex (NASDAQ:ZYXI) has a market capitalization of $300.73 million and generates $158.17 million in revenue each year. The company earns $17.05 million in net income (profit) each year or $0.46 on an earnings per share basis.

How many employees does Zynex have?

The company employs 900 workers across the globe.

How can I contact Zynex?

Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The official website for the company is www.zynex.com. The company can be reached via phone at (303) 703-4906 or via email at info@zynex.com.

This page (NASDAQ:ZYXI) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -